WebDec 31, 2014 · Of each of the five studies the CTCAE hearing loss criteria were used, excluding patients with grade 1 ototoxicity to better differentiate between cisplatin-induced ototoxicity and normal hearing. The studies … WebCategory Toxicity Code CTCAE v5.0 Term CTCAE v5.0 Toxicity Codes Ear and labyrinth disorders 10019245 Hearing impaired Ear and labyrinth disorders 10065838 Middle ear inflammation Ear and labyrinth disorders 10043882 Tinnitus Ear and labyrinth disorders 10047340 Vertigo Ear and labyrinth disorders 10047386 Vestibular disorder
National Center for Biotechnology Information
WebNov 21, 2014 · A statistically significant trend (p <0.05) was observed, indicating that those survivors with more severe CTCAE hearing loss presented a worse outcome in global … WebHearing evaluations were conducted at baseline, before each cisplatin cycle, and at the end of therapy. Audiologic results were assessed and graded by the testing audiologist and … cycloplegics and mydriatics
Hearing loss - Symptoms and causes - Mayo Clinic
Webi.CTCAE(the common terminology criteria for adverse events) v4.0 grade2 audiometric hearing loss ii.CTCAE v4.0 grade2 peripheral neuropathy iii.CIRS(the cumulative illness rating scale) score >6 II.先前已使用過platinum類化學治療失敗後疾病惡化的局部晚期 無法切除或轉移性泌尿道上皮癌成人患者。 WebHearing loss was assessed by use of several methods: the NCI's Common Terminology Criteria of Adverse Events (CTCAE); qualification for a hearing aid; and by the amount of actual post-treatment hearing loss vital for speech perception (defined in frequencies). WebAug 30, 2024 · CTCAE stands for Common Terminology Criteria for Adverse Events; these criteria are also called "common toxicity criteria." In CTCAE, an adverse event (AE) is … cyclopithecus